cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Stockal+Disclaimer.pdf
17 own
17 watching
Current Price
$16.8
$0.94
(5.93%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
585.59M
52-Week High
52-Week High
24.50000
52-Week Low
52-Week Low
8.92000
Average Volume
Average Volume
0.55M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
310.1434
iconMarket Capitalization585.59M
icon52-Week High24.50000
icon52-Week Low8.92000
iconAverage Volume0.55M
iconDividend Yield--
iconP/E Ratio310.1434
What does the Stockal+Disclaimer.pdf do?
BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues in the United States. The company's products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. It offers HypoThermosol FRS, a hypothermic storage and shipping media product to reduce post-preservation necrosis and apoptosis; CryoStor cryopreservation freeze media products, which are designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing; and BloodStor products comprising BloodStor 55-5 and BloodStor 100 for cryopreservation of cells isolated from umbilical cord blood, peripheral blood, and bone marrow. The company also provides cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants; and PrepaStor, a flush solution designed for use during the transitions from normothermic to mild hypothermic conditions to rinse culture media and native fluids from tissue and whole organ systems prior to suspension in a preservation solution. In addition, it offers custom product formulation and custom packaging services; precision thermal packaging products and cloud-hosted Web applications; and contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The company markets its products to the bio banking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. BioLife Solutions, Inc. was founded in 1987 and is based in Bothell, Washington.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Zolmax
1 year ago
BioLife Solutions, Inc. (NASDAQ:BLFS Get Rating) CMO Todd Berard sold 1,545 shares of the businesss stock in a transaction on Thursday, April 6th. The stock was sold at an average price of $20.03, for a total value of $30,946.35. Following the transaction, the chief marketing officer now owns 116,...
Ticker Report
1 year ago
BioLife Solutions, Inc. (NASDAQ:BLFS Get Rating) CMO Todd Berard sold 1,545 shares of BioLife Solutions stock in a transaction that occurred on Thursday, April 6th. The stock was sold at an average price of $20.03, for a total value of $30,946.35. Following the completion of the sale, the ...
Ticker Report
1 year ago
BioLife Solutions, Inc. (NASDAQ:BLFS Get Rating) CRO Marcus Schulz sold 771 shares of BioLife Solutions stock in a transaction that occurred on Thursday, April 6th. The shares were sold at an average price of $20.03, for a total value of $15,443.13. Following the sale, the executive now ...
Ticker Report
1 year ago
BioLife Solutions, Inc. (NASDAQ:BLFS Get Rating) insider Karen A. Foster sold 1,101 shares of the companys stock in a transaction on Thursday, April 6th. The shares were sold at an average price of $20.03, for a total value of $22,053.03. Following the completion of the transaction, ...
Zolmax
1 year ago
BioLife Solutions, Inc. (NASDAQ:BLFS Get Rating) CRO Marcus Schulz sold 771 shares of BioLife Solutions stock in a transaction that occurred on Thursday, April 6th. The shares were sold at an average price of $20.03, for a total value of $15,443.13. Following the sale, the executive now directly ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$16.8
$0.94
(5.93%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$7.74
$-0.46 (-5.61 %)
EVOLV TECHNOLOGIES HOLDINGS
EVOLV TECHNOLOGIES HOLDINGS
$3.88
$0.05 (1.31 %)
Cryoport, Inc.
Cryoport, Inc.
$16.06
$-0.07 (-0.43 %)
Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
$63.85
$0.43 (0.68 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$7.74
$-0.46 (-5.61 %)
EVOLV TECHNOLOGIES HOLDINGS
EVOLV TECHNOLOGIES HOLDINGS
$3.88
$0.05 (1.31 %)
Cryoport, Inc.
Cryoport, Inc.
$16.06
$-0.07 (-0.43 %)
Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
$63.85
$0.43 (0.68 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00